Key references: Migraine in children

  • El-Chammas K, Keyes J, Thompson N, Vijayakumar J, Becher D, Jackson JL. Pharmacologic treatment of pediatric headaches: a meta-analysis. JAMA Pediatr 2013;167(3):250–8. https://www.ncbi.nlm.nih.gov/pubmed/23358935
  • Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 2009;123(3):924–34. https://www.ncbi.nlm.nih.gov/pubmed/19255022
  • Ng QX, Venkatanarayanan N, Kumar L. A systematic review and meta-analysis of the efficacy of cognitive behavioral therapy for the management of pediatric migraine. Headache 2017;57(3):349–62. https://www.ncbi.nlm.nih.gov/pubmed/28028812
  • O'Brien HL, Kabbouche MA, Kacperski J, Hershey AD. Treatment of pediatric migraine. Curr Treat Options Neurol 2015;17(1):326. https://www.ncbi.nlm.nih.gov/pubmed/25617222
  • Orr SL. Diet and nutraceutical interventions for headache management: A review of the evidence. Cephalalgia 2016;36(12):1112–33. https://www.ncbi.nlm.nih.gov/pubmed/26069242
  • Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, et al. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med 2017;376(2):115–24. https://www.ncbi.nlm.nih.gov/pubmed/27788026
  • Richer L, Billinghurst L, Linsdell MA, Russell K, Vandermeer B, Crumley ET, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev 2016;(4):CD005220. https://www.ncbi.nlm.nih.gov/pubmed/27091010
  • Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, et al. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 2005;45(10):1304–12. https://www.ncbi.nlm.nih.gov/pubmed/16324162